-
Je něco špatně v tomto záznamu ?
Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness
VL. Patel, EL. Busch, TM. Friebel, A. Cronin, G. Leslie, L. McGuffog, J. Adlard, S. Agata, BA. Agnarsson, M. Ahmed, K. Aittomäki, E. Alducci, IL. Andrulis, A. Arason, N. Arnold, G. Artioli, B. Arver, B. Auber, J. Azzollini, J. Balmaña, RB....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, práce podpořená grantem, Research Support, U.S. Gov't, Non-P.H.S.
Grantová podpora
203477/Z/16/Z
Wellcome Trust - United Kingdom
CRN-87521
CIHR - Canada
C1287/A 10710
Cancer Research UK - United Kingdom
P50 CA116201
NCI NIH HHS - United States
R01 CA149429
NCI NIH HHS - United States
U19 CA148065
NCI NIH HHS - United States
C1281/A12014
Cancer Research UK - United Kingdom
U10 CA180822
NCI NIH HHS - United States
U10 CA180868
NCI NIH HHS - United States
R03 CA130065
NCI NIH HHS - United States
R01 CA176785
NCI NIH HHS - United States
CRN-87521
CIHR - Canada
RC4 CA153828
NCI NIH HHS - United States
P20 CA233255
NCI NIH HHS - United States
R01 CA142996
NCI NIH HHS - United States
R01 CA140323
NCI NIH HHS - United States
P50 CA125183
NCI NIH HHS - United States
UM1 CA164920
NCI NIH HHS - United States
P30 CA168524
NCI NIH HHS - United States
U01 CA161032
NCI NIH HHS - United States
C12292/A11174
Cancer Research UK - United Kingdom
U10 CA027469
NCI NIH HHS - United States
C5047/A10692
Cancer Research UK - United Kingdom
UL1 TR000124
NCATS NIH HHS - United States
U01 CA116167
NCI NIH HHS - United States
C5047/A8384
Cancer Research UK - United Kingdom
P30 CA008748
NCI NIH HHS - United States
R01 CA214545
NCI NIH HHS - United States
C5047/A8385FCCC
Cancer Research UK - United Kingdom
R01 CA128978
NCI NIH HHS - United States
U19 CA148537
NCI NIH HHS - United States
P30 CA051008
NCI NIH HHS - United States
R01 CA116167
NCI NIH HHS - United States
C12292/A20861
Cancer Research UK - United Kingdom
U10 CA037517
NCI NIH HHS - United States
P20 GM130423
NIGMS NIH HHS - United States
R25 CA112486
NCI NIH HHS - United States
C5047/A15007
Cancer Research UK - United Kingdom
N02CP65504
NCI NIH HHS - United States
P50 CA105641
NCI NIH HHS - United States
T32 CA009001
NCI NIH HHS - United States
U19 CA148112
NCI NIH HHS - United States
C8197/A16565
Cancer Research UK - United Kingdom
10118
Cancer Research UK - United Kingdom
R01 CA192393
NCI NIH HHS - United States
C12292/A11174
Cancer Research UK - United Kingdom
N02CP11019
NCI NIH HHS - United States
NLK
Free Medical Journals
od 1941 do Před 1 rokem
Freely Accessible Science Journals
od 1941 do Před 1 rokem
Open Access Digital Library
od 1941-01-01
Open Access Digital Library
od 1941-01-01
- MeSH
- dospělí MeSH
- genetická predispozice k nemoci * MeSH
- genetické asociační studie MeSH
- genomika metody MeSH
- heterozygot MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mutace * MeSH
- nádory prostaty genetika patologie MeSH
- prognóza MeSH
- protein BRCA1 genetika MeSH
- protein BRCA2 genetika MeSH
- rizikové faktory MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
- Research Support, N.I.H., Intramural MeSH
- Research Support, U.S. Gov't, Non-P.H.S. MeSH
Pathogenic sequence variants (PSV) in BRCA1 or BRCA2 (BRCA1/2) are associated with increased risk and severity of prostate cancer. We evaluated whether PSVs in BRCA1/2 were associated with risk of overall prostate cancer or high grade (Gleason 8+) prostate cancer using an international sample of 65 BRCA1 and 171 BRCA2 male PSV carriers with prostate cancer, and 3,388 BRCA1 and 2,880 BRCA2 male PSV carriers without prostate cancer. PSVs in the 3' region of BRCA2 (c.7914+) were significantly associated with elevated risk of prostate cancer compared with reference bin c.1001-c.7913 [HR = 1.78; 95% confidence interval (CI), 1.25-2.52; P = 0.001], as well as elevated risk of Gleason 8+ prostate cancer (HR = 3.11; 95% CI, 1.63-5.95; P = 0.001). c.756-c.1000 was also associated with elevated prostate cancer risk (HR = 2.83; 95% CI, 1.71-4.68; P = 0.00004) and elevated risk of Gleason 8+ prostate cancer (HR = 4.95; 95% CI, 2.12-11.54; P = 0.0002). No genotype-phenotype associations were detected for PSVs in BRCA1. These results demonstrate that specific BRCA2 PSVs may be associated with elevated risk of developing aggressive prostate cancer. SIGNIFICANCE: Aggressive prostate cancer risk in BRCA2 mutation carriers may vary according to the specific BRCA2 mutation inherited by the at-risk individual.
Cancer Research Initiatives Foundation Sime Darby Medical Centre Subang Jaya Selangor Malaysia
Center for Clinical Cancer Genetics The University of Chicago Chicago Illinois
Center for Genomic Medicine Rigshospitalet Copenhagen University Hospital Copenhagen Denmark
Centre for Medical Genetics Ghent University Ghent Belgium
Clinical Cancer Genetics City of Hope Duarte California
Clinical Genetic Unit Department of Paediatrics Zealand University Hospital Roskilde Denmark
Clinical Genetics Amsterdam UMC Vrije Universiteit Amsterdam Amsterdam the Netherlands
Clinical Genetics Department St Michael's Hospital Bristol United Kingdom
Clinical Genetics Guy's and St Thomas' NHS Foundation Trust London United Kingdom
Clinical Genetics Karolinska Institutet Stockholm Sweden
Dana Farber Cancer Institute Boston Massachusetts
Département d'Hématologie Oncologie Médicale Centre Antoine Lacassagne Nice France
Department of Cancer Biology and Genetics The Ohio State University Columbus Ohio
Department of Cancer Epidemiology and Genetics Masaryk Memorial Cancer Institute Brno Czech Republic
Department of Chemotherapy National Institute of Oncology Budapest Hungary
Department of Clinical Genetics Aalborg University Hospital Aalborg Denmark
Department of Clinical Genetics Aarhus University Hospital Aarhus Denmark
Department of Clinical Genetics Alder Hey Hospital Liverpool United Kingdom
Department of Clinical Genetics Fox Chase Cancer Center Philadelphia Pennsylvania
Department of Clinical Genetics Helsinki University Hospital University of Helsinki Helsinki Finland
Department of Clinical Genetics Leiden University Medical Center Leiden the Netherlands
Department of Clinical Genetics Lund University Hospital Lund Sweden
Department of Clinical Genetics Maastricht University Medical Center Maastricht the Netherlands
Department of Clinical Genetics Odense University Hospital Odense Denmark
Department of Clinical Genetics Rigshospitalet Copenhagen Denmark
Department of Clinical Genetics Royal Devon and Exeter Hospital Exeter United Kingdom
Department of Clinical Genetics South Glasgow University Hospitals Glasgow United Kingdom
Department of Clinical Genetics Vejle Hospital Vejle Denmark
Department of Clinical Genetics VU University Medical Center Amsterdam the Netherlands
Department of Epidemiology The Netherlands Cancer Institute Amsterdam the Netherlands
Department of Genetics Portuguese Oncology Institute Porto Portugal
Department of Gynaecology and Obstetrics University Hospital Ulm Ulm Germany
Department of Gynecology and Obstetrics Ludwig Maximilian University of Munich Munich Germany
Department of Gynecology and Obstetrics Technical University of Dresden Dresden Germany
Department of Human Genetics Radboud University Medical Center Nijmegen the Netherlands
Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota
Department of Medical and Biological Sciences University of Udine Udine Italy
Department of Medical Genetics University Medical Center Utrecht the Netherlands
Department of Medical Oncology Beth Israel Deaconess Medical Center Boston Massachusetts
Department of Medicine Huntsman Cancer Institute Salt Lake City Utah
Department of Molecular Genetics National Institute of Oncology Budapest Hungary
Department of Molecular Medicine University La Sapienza Rome Italy
Department of OB GYN Medical University of Vienna Vienna Austria
Department of Oncology and Haematology University of Modena and Reggio Emilia Modena Italy
Department of Oncology Hospital Clinico San Carlos IdISSC Madrid Spain
Department of Oncology Karolinska Institutet Stockholm Sweden
Department of Oncology Landspitali University Hospital Reykjavik Iceland
Department of Oncology Lund University and Skåne University Hospital Lund Sweden
Department of Oncology Mayo Clinic Rochester Minnesota
Department of Oncology Rigshospitalet Copenhagen University Hospital Copenhagen Denmark
Department of Pathology and Laboratory Medicine Kansas University Medical Center Kansas City Kansas
Department of Population Sciences Beckman Research Institute of City of Hope Duarte California
Department of Preventive Medicine Gacheon University College of Medicine Incheon Republic of Korea
Department of Surgery Daerim Saint Mary's Hospital Seoul Korea
Department of Surgery Seoul National University Bundang Hospital Seongnam Korea
Department of Surgery Soonchunhyang University Bucheon Hospital Bucheon Korea
Department of Surgery The University of Hong Kong Pok Fu Lam Hong Kong
Department of Surgery Ulsan University College of Medicine and Asan Medical Center Seoul Korea
Department of Urology Medical University of Vienna Vienna Austria
Department of Women's Health Tubingen University Hospital Tubingen Germany
Departments of Pediatrics and Medicine Columbia University New York New York
Dept of OB GYN and Comprehensive Cancer Center Medical University of Vienna Vienna Austria
Division of Cancer Prevention and Genetics IEO European Institute of Oncology IRCCS Milan Italy
Genome Diagnostics Program IFOM the FIRC Institute of Molecular Oncology Milan Italy
Hong Kong Hereditary Breast Cancer Family Registry Cancer Genetics Centre Happy Valley Hong Kong
Human Cancer Genetics Programme Spanish National Cancer Research Centre Madrid Spain
Human Genetics Group Spanish National Cancer Research Centre Madrid Spain
Immunology and Molecular Oncology Unit Veneto Institute of Oncology IOV IRCCS Padua Italy
Institute of Cancer and Genomic Sciences University of Birmingham Birmingham United Kingdom
Institute of Cell and Molecular Pathology Hannover Medical School Hannover Germany
Institute of Human Genetics Hannover Medical School Hannover Germany
Institute of Human Genetics University Hospital Heidelberg Heidelberg Germany
Institute of Human Genetics University Hospital Leipzig Leipzig Germany
Institute of Human Genetics University of Münster Münster Germany
Institute of Medical Genetics and Applied Genomics University of Tübingen Tübingen Germany
Istituto Nazionale Tumori 'Giovanni Paolo 2 Bari Italy
Latvian Biomedical Research and Study Centre Riga Latvia
Magee Womens Hospital University of Pittsburgh School of Medicine Pittsburgh Pennsylvania
Medical Genetics Unit St George's University of London London United Kingdom
Molecular Genetics of Breast Cancer German Cancer Research Center Heidelberg Germany
Molecular Genetics of Breast Cancer German Cancer Research Center Lahore Pakistan
Parkville Familial Cancer Centre Peter MacCallum Cancer Center Melbourne Victoria Australia
Section of Molecular Diagnostics Clinical Biochemistry Aalborg University Hospital Aalborg Denmark
Service de Génétique Institut Curie Paris France
Service Régional Oncogénétique Poitou Charentes CH Niort Niort France
Sheffield Clinical Genetics Service Sheffield Children's Hospital Sheffield United Kingdom
South East of Scotland Regional Genetics Service Western General Hospital Edinburgh United Kingdom
Translational Research Laboratory IDIBELL Catalan Institute of Oncology CIBERONC Barcelona Spain
ULSS 3 Serenissima U O C Oncologia ed Ematologia Oncologica Mirano Venice Italy
Unité d'oncogénétique Centre de Lutte Contre le Cancer Centre Georges François Leclerc Dijon France
Unité d'Oncogénétique Centre de Lutte Contre le Cancer Paul Strauss Strasbourg France
Unité de Prévention et d'Epidémiologie Génétique Centre Léon Bérard Lyon France
UO Anatomia Patologica Ospedale di Circolo Università dell'Insubria Varese Italy
Yorkshire Regional Genetics Service Chapel Allerton Hospital Leeds United Kingdom
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025213
- 003
- CZ-PrNML
- 005
- 20201222155120.0
- 007
- ta
- 008
- 201125s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1158/0008-5472.CAN-19-1840 $2 doi
- 035 __
- $a (PubMed)31723001
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Patel, Vivek L $u Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.
- 245 10
- $a Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness / $c VL. Patel, EL. Busch, TM. Friebel, A. Cronin, G. Leslie, L. McGuffog, J. Adlard, S. Agata, BA. Agnarsson, M. Ahmed, K. Aittomäki, E. Alducci, IL. Andrulis, A. Arason, N. Arnold, G. Artioli, B. Arver, B. Auber, J. Azzollini, J. Balmaña, RB. Barkardottir, DR. Barnes, A. Barroso, D. Barrowdale, M. Belotti, J. Benitez, B. Bertelsen, MJ. Blok, I. Bodrogi, V. Bonadona, B. Bonanni, D. Bondavalli, SE. Boonen, J. Borde, A. Borg, AR. Bradbury, A. Brady, C. Brewer, J. Brunet, B. Buecher, SS. Buys, S. Cabezas-Camarero, T. Caldés, A. Caliebe, MA. Caligo, M. Calvello, IG. Campbell, I. Carnevali, E. Carrasco, TL. Chan, ATW. Chu, WK. Chung, KBM. Claes, GS. Collaborators, E. Collaborators, J. Cook, L. Cortesi, FJ. Couch, MB. Daly, G. Damante, E. Darder, R. Davidson, M. de la Hoya, LD. Puppa, J. Dennis, O. Díez, YC. Ding, N. Ditsch, SM. Domchek, A. Donaldson, B. Dworniczak, DF. Easton, DM. Eccles, RA. Eeles, H. Ehrencrona, B. Ejlertsen, C. Engel, DG. Evans, L. Faivre, U. Faust, L. Feliubadaló, L. Foretova, F. Fostira, G. Fountzilas, D. Frost, V. García-Barberán, P. Garre, M. Gauthier-Villars, L. Géczi, A. Gehrig, AM. Gerdes, P. Gesta, G. Giannini, G. Glendon, AK. Godwin, DE. Goldgar, MH. Greene, AM. Gutierrez-Barrera, E. Hahnen, U. Hamann, J. Hauke, N. Herold, FBL. Hogervorst, E. Honisch, JL. Hopper, PJ. Hulick, K. Investigators, H. Investigators, L. Izatt, A. Jager, P. James, R. Janavicius, UB. Jensen, TD. Jensen, OT. Johannsson, EM. John, V. Joseph, E. Kang, K. Kast, JI. Kiiski, SW. Kim, Z. Kim, KP. Ko, I. Konstantopoulou, G. Kramer, L. Krogh, TA. Kruse, A. Kwong, M. Larsen, C. Lasset, C. Lautrup, C. Lazaro, J. Lee, JW. Lee, MH. Lee, J. Lemke, F. Lesueur, A. Liljegren, A. Lindblom, P. Llovet, A. Lopez-Fernández, I. Lopez-Perolio, V. Lorca, JT. Loud, ESK. Ma, PL. Mai, S. Manoukian, V. Mari, L. Martin, L. Matricardi, N. Mebirouk, V. Medici, HEJ. Meijers-Heijboer, A. Meindl, AR. Mensenkamp, C. Miller, DM. Gomes, M. Montagna, TM. Mooij, L. Moserle, E. Mouret-Fourme, AM. Mulligan, KL. Nathanson, M. Navratilova, H. Nevanlinna, D. Niederacher, FCC. Nielsen, L. Nikitina-Zake, K. Offit, E. Olah, OI. Olopade, KR. Ong, A. Osorio, CE. Ott, D. Palli, SK. Park, MT. Parsons, IS. Pedersen, B. Peissel, A. Peixoto, P. Pérez-Segura, P. Peterlongo, AH. Petersen, ME. Porteous, MA. Pujana, P. Radice, J. Ramser, J. Rantala, MU. Rashid, K. Rhiem, P. Rizzolo, ME. Robson, MA. Rookus, CM. Rossing, KJ. Ruddy, C. Santos, C. Saule, R. Scarpitta, RK. Schmutzler, H. Schuster, L. Senter, CM. Seynaeve, PD. Shah, P. Sharma, VY. Shin, V. Silvestri, J. Simard, CF. Singer, AB. Skytte, K. Snape, AR. Solano, P. Soucy, MC. Southey, AB. Spurdle, L. Steele, D. Steinemann, D. Stoppa-Lyonnet, A. Stradella, L. Sunde, C. Sutter, YY. Tan, MR. Teixeira, SH. Teo, M. Thomassen, MG. Tibiletti, M. Tischkowitz, S. Tognazzo, AE. Toland, S. Tommasi, D. Torres, A. Toss, AH. Trainer, N. Tung, CJ. van Asperen, FH. van der Baan, LE. van der Kolk, RB. van der Luijt, LP. van Hest, L. Varesco, R. Varon-Mateeva, A. Viel, J. Vierstraete, R. Villa, A. von Wachenfeldt, P. Wagner, S. Wang-Gohrke, B. Wappenschmidt, JN. Weitzel, G. Wieme, S. Yadav, D. Yannoukakos, SY. Yoon, C. Zanzottera, KK. Zorn, AV. D'Amico, ML. Freedman, MM. Pomerantz, G. Chenevix-Trench, AC. Antoniou, SL. Neuhausen, L. Ottini, HR. Nielsen, TR. Rebbeck,
- 520 9_
- $a Pathogenic sequence variants (PSV) in BRCA1 or BRCA2 (BRCA1/2) are associated with increased risk and severity of prostate cancer. We evaluated whether PSVs in BRCA1/2 were associated with risk of overall prostate cancer or high grade (Gleason 8+) prostate cancer using an international sample of 65 BRCA1 and 171 BRCA2 male PSV carriers with prostate cancer, and 3,388 BRCA1 and 2,880 BRCA2 male PSV carriers without prostate cancer. PSVs in the 3' region of BRCA2 (c.7914+) were significantly associated with elevated risk of prostate cancer compared with reference bin c.1001-c.7913 [HR = 1.78; 95% confidence interval (CI), 1.25-2.52; P = 0.001], as well as elevated risk of Gleason 8+ prostate cancer (HR = 3.11; 95% CI, 1.63-5.95; P = 0.001). c.756-c.1000 was also associated with elevated prostate cancer risk (HR = 2.83; 95% CI, 1.71-4.68; P = 0.00004) and elevated risk of Gleason 8+ prostate cancer (HR = 4.95; 95% CI, 2.12-11.54; P = 0.0002). No genotype-phenotype associations were detected for PSVs in BRCA1. These results demonstrate that specific BRCA2 PSVs may be associated with elevated risk of developing aggressive prostate cancer. SIGNIFICANCE: Aggressive prostate cancer risk in BRCA2 mutation carriers may vary according to the specific BRCA2 mutation inherited by the at-risk individual.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a protein BRCA1 $x genetika $7 D019313
- 650 _2
- $a protein BRCA2 $x genetika $7 D024682
- 650 _2
- $a genetické asociační studie $7 D056726
- 650 12
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a genomika $x metody $7 D023281
- 650 _2
- $a heterozygot $7 D006579
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a nádory prostaty $x genetika $x patologie $7 D011471
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a Research Support, N.I.H., Intramural $7 D052060
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
- 700 1_
- $a Busch, Evan L $u Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
- 700 1_
- $a Friebel, Tara M $u Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Dana-Farber Cancer Institute. Boston, Massachusetts.
- 700 1_
- $a Cronin, Angel $u Dana-Farber Cancer Institute. Boston, Massachusetts.
- 700 1_
- $a Leslie, Goska $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
- 700 1_
- $a McGuffog, Lesley $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
- 700 1_
- $a Adlard, Julian $u Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, United Kingdom.
- 700 1_
- $a Agata, Simona $u Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
- 700 1_
- $a Agnarsson, Bjarni A $u Department of Pathology, Landspitali University Hospital, 101, Reykjavik, Iceland. School of Medicine, University of Iceland, Reykjavik, Iceland.
- 700 1_
- $a Ahmed, Munaza $u North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom.
- 700 1_
- $a Aittomäki, Kristiina $u Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
- 700 1_
- $a Alducci, Elisa $u Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
- 700 1_
- $a Andrulis, Irene L $u Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
- 700 1_
- $a Arason, Adalgeir $u Department of Pathology, Landspitali University Hospital, 101, Reykjavik, Iceland. BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
- 700 1_
- $a Arnold, Norbert $u Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
- 700 1_
- $a Artioli, Grazia $u ULSS 3 Serenissima, U.O.C. Oncologia ed Ematologia Oncologica, Mirano, Venice, Italy.
- 700 1_
- $a Arver, Brita $u Department of Oncology, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Auber, Bernd $u Institute of Human Genetics, Hannover Medical School, Hannover, Germany.
- 700 1_
- $a Azzollini, Jacopo $u Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy.
- 700 1_
- $a Balmaña, Judith $u High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Barcelona, Spain.
- 700 1_
- $a Barkardottir, Rosa B $u Department of Pathology, Landspitali University Hospital, 101, Reykjavik, Iceland. BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
- 700 1_
- $a Barnes, Daniel R $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
- 700 1_
- $a Barroso, Alicia $u Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
- 700 1_
- $a Barrowdale, Daniel $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
- 700 1_
- $a Belotti, Muriel $u Service de Génétique, Institut Curie, Paris, France.
- 700 1_
- $a Benitez, Javier $u Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
- 700 1_
- $a Bertelsen, Birgitte $u Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- 700 1_
- $a Blok, Marinus J $u Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands.
- 700 1_
- $a Bodrogi, Istvan $u Department of Chemotherapy, National Institute of Oncology, Budapest, Hungary.
- 700 1_
- $a Bonadona, Valérie $u Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France.
- 700 1_
- $a Bonanni, Bernardo $u Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.
- 700 1_
- $a Bondavalli, Davide $u Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.
- 700 1_
- $a Boonen, Susanne E $u Clinical Genetic Unit, Department of Paediatrics, Zealand University Hospital, Roskilde, Denmark.
- 700 1_
- $a Borde, Julika $u Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
- 700 1_
- $a Borg, Ake $u Department of Oncology, Lund University and Skåne University Hospital, Lund, Sweden.
- 700 1_
- $a Bradbury, Angela R $u Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
- 700 1_
- $a Brady, Angela $u North West Thames Regional Genetics Service, Kennedy Galton Centre, The North West London Hospitals NHS Trust, Middlesex, United Kingdom.
- 700 1_
- $a Brewer, Carole $u Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom.
- 700 1_
- $a Brunet, Joan $u Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, CIBERONC, Girona, Spain.
- 700 1_
- $a Buecher, Bruno $u Service de Génétique, Institut Curie, Paris, France.
- 700 1_
- $a Buys, Saundra S $u Department of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah.
- 700 1_
- $a Cabezas-Camarero, Santiago $u Department of Oncology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain.
- 700 1_
- $a Caldés, Trinidad $u Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
- 700 1_
- $a Caliebe, Almuth $u Institute of Human Genetics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
- 700 1_
- $a Caligo, Maria A $u Section of Molecular Genetics, Department of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy.
- 700 1_
- $a Calvello, Mariarosaria $u Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.
- 700 1_
- $a Campbell, Ian G $u Peter MacCallum Cancer Center, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
- 700 1_
- $a Carnevali, Ileana $u UO Anatomia Patologica, Ospedale di Circolo-Università dell'Insubria, Varese, Italy.
- 700 1_
- $a Carrasco, Estela $u High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Barcelona, Spain.
- 700 1_
- $a Chan, Tsun L $u Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong. Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.
- 700 1_
- $a Chu, Annie T W $u Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong.
- 700 1_
- $a Chung, Wendy K $u Departments of Pediatrics and Medicine, Columbia University, New York, New York.
- 700 1_
- $a Claes, Kathleen B M $u Centre for Medical Genetics, Ghent University, Ghent, Belgium.
- 700 1_
- $a Collaborators, Gemo Study $u Service de Génétique, Institut Curie, Paris, France.
- 700 1_
- $a Collaborators, Embrace $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
- 700 1_
- $a Cook, Jackie $u Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, United Kingdom.
- 700 1_
- $a Cortesi, Laura $u Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy.
- 700 1_
- $a Couch, Fergus J $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
- 700 1_
- $a Daly, Mary B $u Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
- 700 1_
- $a Damante, Giuseppe $u Department of Medical and Biological Sciences, University of Udine, Udine, Italy.
- 700 1_
- $a Darder, Esther $u Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, CIBERONC, Girona, Spain.
- 700 1_
- $a Davidson, Rosemarie $u Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, United Kingdom.
- 700 1_
- $a de la Hoya, Miguel $u Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
- 700 1_
- $a Puppa, Lara Della $u Division of Functional Onco-genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
- 700 1_
- $a Dennis, Joe $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
- 700 1_
- $a Díez, Orland $u Oncogenetics Group, Clinical and Molecular Genetics Area, Vall d'Hebron Institute of Oncology (VHIO), University Hospital, Barcelona, Spain.
- 700 1_
- $a Ding, Yuan Chun $u Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California.
- 700 1_
- $a Ditsch, Nina $u Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich, Munich, Germany.
- 700 1_
- $a Domchek, Susan M $u Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
- 700 1_
- $a Donaldson, Alan $u Clinical Genetics Department, St Michael's Hospital, Bristol, United Kingdom.
- 700 1_
- $a Dworniczak, Bernd $u Institute of Human Genetics, University of Münster, Münster, Germany.
- 700 1_
- $a Easton, Douglas F $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
- 700 1_
- $a Eccles, Diana M $u Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
- 700 1_
- $a Eeles, Rosalind A $u Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
- 700 1_
- $a Ehrencrona, Hans $u Department of Clinical Genetics, Lund University Hospital, Lund, Sweden.
- 700 1_
- $a Ejlertsen, Bent $u Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- 700 1_
- $a Engel, Christoph $u Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
- 700 1_
- $a Evans, D Gareth $u Division of Evolution and Genomic Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health and Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom. Manchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust and Manchester Academic Health Science Centre, Manchester, United Kingdom.
- 700 1_
- $a Faivre, Laurence $u Unité d'oncogénétique, Centre de Lutte Contre le Cancer, Centre Georges-François Leclerc, Dijon, France.
- 700 1_
- $a Faust, Ulrike $u Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
- 700 1_
- $a Feliubadaló, Lídia $u Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.
- 700 1_
- $a Foretova, Lenka $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
- 700 1_
- $a Fostira, Florentia $u Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research "Demokritos", Athens, Greece.
- 700 1_
- $a Fountzilas, George $u Second Department of Medical Oncology, EUROMEDICA General Clinic of Thessaloniki, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece.
- 700 1_
- $a Frost, Debra $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
- 700 1_
- $a García-Barberán, Vanesa $u Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
- 700 1_
- $a Garre, Pilar $u Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
- 700 1_
- $a Gauthier-Villars, Marion $u Service de Génétique, Institut Curie, Paris, France.
- 700 1_
- $a Géczi, Lajos $u Department of Chemotherapy, National Institute of Oncology, Budapest, Hungary.
- 700 1_
- $a Gehrig, Andrea $u Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University of Würzburg, Würzburg, Germany.
- 700 1_
- $a Gerdes, Anne-Marie $u Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark.
- 700 1_
- $a Gesta, Paul $u Service Régional Oncogénétique Poitou-Charentes, CH Niort, Niort, France.
- 700 1_
- $a Giannini, Giuseppe $u Department of Molecular Medicine, University La Sapienza, Rome, Italy.
- 700 1_
- $a Glendon, Gord $u Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
- 700 1_
- $a Godwin, Andrew K $u Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, Kansas.
- 700 1_
- $a Goldgar, David E $u Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah.
- 700 1_
- $a Greene, Mark H $u Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
- 700 1_
- $a Gutierrez-Barrera, Angelica M $u Department of Breast Medical Oncology and Clinical Genetics Program, University of Texas MD Anderson Cancer Center, Houston, Texas.
- 700 1_
- $a Hahnen, Eric $u Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
- 700 1_
- $a Hamann, Ute $u Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 700 1_
- $a Hauke, Jan $u Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
- 700 1_
- $a Herold, Natalie $u Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
- 700 1_
- $a Hogervorst, Frans B L $u Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
- 700 1_
- $a Honisch, Ellen $u Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
- 700 1_
- $a Hopper, John L $u Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
- 700 1_
- $a Hulick, Peter J $u Center for Medical Genetics, NorthShore University HealthSystem, Evanston, Illinois. The University of Chicago Pritzker School of Medicine, Chicago, Illinois.
- 700 1_
- $a Investigators, KConFab $u Peter MacCallum Cancer Center, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
- 700 1_
- $a Investigators, Hebon $u The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Coordinating center: The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- 700 1_
- $a Izatt, Louise $u Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
- 700 1_
- $a Jager, Agnes $u Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
- 700 1_
- $a James, Paul $u Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia. Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
- 700 1_
- $a Janavicius, Ramunas $u Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania.
- 700 1_
- $a Jensen, Uffe Birk $u Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
- 700 1_
- $a Jensen, Thomas Dyrso $u Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
- 700 1_
- $a Johannsson, Oskar Th $u Department of Oncology, Landspitali University Hospital, Reykjavik, Iceland.
- 700 1_
- $a John, Esther M $u Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.
- 700 1_
- $a Joseph, Vijai $u Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York.
- 700 1_
- $a Kang, Eunyoung $u Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
- 700 1_
- $a Kast, Karin $u Department of Gynecology and Obstetrics, Technical University of Dresden, Dresden, Germany.
- 700 1_
- $a Kiiski, Johanna I $u Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
- 700 1_
- $a Kim, Sung-Won $u Department of Surgery, Daerim Saint Mary's Hospital, Seoul, Korea.
- 700 1_
- $a Kim, Zisun $u Department of Surgery, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
- 700 1_
- $a Ko, Kwang-Pil $u Department of Preventive Medicine, Gacheon University College of Medicine, Incheon, Republic of Korea.
- 700 1_
- $a Konstantopoulou, Irene $u Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research "Demokritos", Athens, Greece.
- 700 1_
- $a Kramer, Gero $u Department of Urology, Medical University of Vienna, Vienna, Austria.
- 700 1_
- $a Krogh, Lotte $u Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
- 700 1_
- $a Kruse, Torben A $u Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
- 700 1_
- $a Kwong, Ava $u Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong. Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong. Department of Surgery, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.
- 700 1_
- $a Larsen, Mirjam $u Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
- 700 1_
- $a Lasset, Christine $u Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France.
- 700 1_
- $a Lautrup, Charlotte $u Department of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark.
- 700 1_
- $a Lazaro, Conxi $u Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.
- 700 1_
- $a Lee, Jihyoun $u Department of Surgery, Soonchunhyang University College of Medicine and Soonchunhyang University Hospital, Seoul, Korea.
- 700 1_
- $a Lee, Jong Won $u Department of Surgery, Ulsan University College of Medicine and Asan Medical Center, Seoul, Korea.
- 700 1_
- $a Lee, Min Hyuk $u Department of Surgery, Soonchunhyang University College of Medicine and Soonchunhyang University Hospital, Seoul, Korea.
- 700 1_
- $a Lemke, Johannes $u Institute of Human Genetics, University Hospital Leipzig, Leipzig, Germany.
- 700 1_
- $a Lesueur, Fabienne $u Service de Génétique, Institut Curie, Paris, France. Genetic Epidemiology of Cancer Team, Inserm U900, Paris, France. Institut Curie, Paris, France. Mines ParisTech, Fontainebleau, France.
- 700 1_
- $a Liljegren, Annelie $u Department of Oncology, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Lindblom, Annika $u Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
- 700 1_
- $a Llovet, Patricia $u Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
- 700 1_
- $a Lopez-Fernández, Adria $u High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Barcelona, Spain.
- 700 1_
- $a Lopez-Perolio, Irene $u Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
- 700 1_
- $a Lorca, Victor $u Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
- 700 1_
- $a Loud, Jennifer T $u Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
- 700 1_
- $a Ma, Edmond S K $u Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong. Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.
- 700 1_
- $a Mai, Phuong L $u Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
- 700 1_
- $a Manoukian, Siranoush $u Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy.
- 700 1_
- $a Mari, Veronique $u Département d'Hématologie-Oncologie Médicale, Centre Antoine Lacassagne, Nice, France.
- 700 1_
- $a Martin, Lynn $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
- 700 1_
- $a Matricardi, Laura $u Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
- 700 1_
- $a Mebirouk, Noura $u Service de Génétique, Institut Curie, Paris, France. Genetic Epidemiology of Cancer Team, Inserm U900, Paris, France. Institut Curie, Paris, France. Mines ParisTech, Fontainebleau, France.
- 700 1_
- $a Medici, Veronica $u Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy.
- 700 1_
- $a Meijers-Heijboer, Hanne E J $u Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
- 700 1_
- $a Meindl, Alfons $u Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich, Munich, Germany.
- 700 1_
- $a Mensenkamp, Arjen R $u Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
- 700 1_
- $a Miller, Clare $u Department of Clinical Genetics, Alder Hey Hospital, Liverpool, United Kingdom.
- 700 1_
- $a Gomes, Denise Molina $u Service de Biologie de la Reproduction, Cytogénétique et Génétique Médicale, CHI Poissy - Saint Germain, Poissy, France.
- 700 1_
- $a Montagna, Marco $u Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
- 700 1_
- $a Mooij, Thea M $u Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- 700 1_
- $a Moserle, Lidia $u Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
- 700 1_
- $a Mouret-Fourme, Emmanuelle $u Service de Génétique, Institut Curie, Paris, France.
- 700 1_
- $a Mulligan, Anna Marie $u Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
- 700 1_
- $a Nathanson, Katherine L $u Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
- 700 1_
- $a Navratilova, Marie $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
- 700 1_
- $a Nevanlinna, Heli $u Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
- 700 1_
- $a Niederacher, Dieter $u Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
- 700 1_
- $a Nielsen, Finn C Cilius $u Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- 700 1_
- $a Nikitina-Zake, Liene $u Latvian Biomedical Research and Study Centre, Riga, Latvia.
- 700 1_
- $a Offit, Kenneth $u Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea. Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.
- 700 1_
- $a Olah, Edith $u Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
- 700 1_
- $a Olopade, Olufunmilayo I $u Center for Clinical Cancer Genetics, The University of Chicago, Chicago, Illinois.
- 700 1_
- $a Ong, Kai-Ren $u West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Birmingham, United Kingdom.
- 700 1_
- $a Osorio, Ana $u Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
- 700 1_
- $a Ott, Claus-Eric $u Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
- 700 1_
- $a Palli, Domenico $u Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
- 700 1_
- $a Park, Sue K $u Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea. Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea. Cancer Research Institute, Seoul National University, Seoul, Korea.
- 700 1_
- $a Parsons, Michael T $u Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
- 700 1_
- $a Pedersen, Inge Sokilde $u Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
- 700 1_
- $a Peissel, Bernard $u Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy.
- 700 1_
- $a Peixoto, Ana $u Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
- 700 1_
- $a Pérez-Segura, Pedro $u Department of Oncology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain.
- 700 1_
- $a Peterlongo, Paolo $u Genome Diagnostics Program, IFOM - the FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy.
- 700 1_
- $a Petersen, Annabeth Høgh $u Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
- 700 1_
- $a Porteous, Mary E $u South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom.
- 700 1_
- $a Pujana, Miguel Angel $u Translational Research Laboratory, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.
- 700 1_
- $a Radice, Paolo $u Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, in Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy.
- 700 1_
- $a Ramser, Juliane $u Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
- 700 1_
- $a Rantala, Johanna $u Clinical Genetics, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Rashid, Muhammad U $u Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan.
- 700 1_
- $a Rhiem, Kerstin $u Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
- 700 1_
- $a Rizzolo, Piera $u Department of Molecular Medicine, University La Sapienza, Rome, Italy.
- 700 1_
- $a Robson, Mark E $u Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.
- 700 1_
- $a Rookus, Matti A $u Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- 700 1_
- $a Rossing, Caroline M $u Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- 700 1_
- $a Ruddy, Kathryn J $u Department of Oncology, Mayo Clinic, Rochester, Minnesota.
- 700 1_
- $a Santos, Catarina $u Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
- 700 1_
- $a Saule, Claire $u Service de Génétique, Institut Curie, Paris, France.
- 700 1_
- $a Scarpitta, Rosa $u Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa, Italy.
- 700 1_
- $a Schmutzler, Rita K $u Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
- 700 1_
- $a Schuster, Hélène $u Unité d'Oncogénétique, Centre de Lutte Contre le Cancer Paul Strauss, Strasbourg, France.
- 700 1_
- $a Senter, Leigha $u Clinical Cancer Genetics Program, Division of Human Genetics, Department of Internal Medicine, The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
- 700 1_
- $a Seynaeve, Caroline M $u Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
- 700 1_
- $a Shah, Payal D $u Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
- 700 1_
- $a Sharma, Priyanka $u Department of Internal Medicine, Division of Oncology, University of Kansas Medical Center, Westwood, Kansas.
- 700 1_
- $a Shin, Vivian Y $u Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong.
- 700 1_
- $a Silvestri, Valentina $u Department of Molecular Medicine, University La Sapienza, Rome, Italy.
- 700 1_
- $a Simard, Jacques $u Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval, Research Centre, Québec City, Québec, Canada.
- 700 1_
- $a Singer, Christian F $u Dept of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
- 700 1_
- $a Skytte, Anne-Bine $u Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
- 700 1_
- $a Snape, Katie $u Medical Genetics Unit, St George's, University of London, London, United Kingdom.
- 700 1_
- $a Solano, Angela R $u INBIOMED, Faculty of Medicine/CONICET and CEMIC, Department of Clinical Chemistry, Medical Direction, University of Buenos Aires, Buenos Aires, Argentina.
- 700 1_
- $a Soucy, Penny $u Department of Internal Medicine, Division of Oncology, University of Kansas Medical Center, Westwood, Kansas.
- 700 1_
- $a Southey, Melissa C $u Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia. Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.
- 700 1_
- $a Spurdle, Amanda B $u Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
- 700 1_
- $a Steele, Linda $u Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California.
- 700 1_
- $a Steinemann, Doris $u Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany.
- 700 1_
- $a Stoppa-Lyonnet, Dominique $u Service de Génétique, Institut Curie, Paris, France. Department of Tumour Biology, INSERM U830, Paris, France. Université Paris Descartes, Paris, France.
- 700 1_
- $a Stradella, Agostina $u Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.
- 700 1_
- $a Sunde, Lone $u Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
- 700 1_
- $a Sutter, Christian $u Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.
- 700 1_
- $a Tan, Yen Y $u Department of OB/GYN, Medical University of Vienna, Vienna, Austria.
- 700 1_
- $a Teixeira, Manuel R $u Department of Genetics, Portuguese Oncology Institute, Porto, Portugal. Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal.
- 700 1_
- $a Teo, Soo Hwang $u Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia. Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia.
- 700 1_
- $a Thomassen, Mads $u Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
- 700 1_
- $a Tibiletti, Maria Grazia $u UO Anatomia Patologica, Ospedale di Circolo-Università dell'Insubria, Varese, Italy.
- 700 1_
- $a Tischkowitz, Marc $u Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, Quebec, Canada. Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.
- 700 1_
- $a Tognazzo, Silvia $u Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
- 700 1_
- $a Toland, Amanda E $u Department of Cancer Biology and Genetics, The Ohio State University, Columbus, Ohio.
- 700 1_
- $a Tommasi, Stefania $u Istituto Nazionale Tumori 'Giovanni Paolo II, Bari, Italy.
- 700 1_
- $a Torres, Diana $u Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia.
- 700 1_
- $a Toss, Angela $u Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy.
- 700 1_
- $a Trainer, Alison H $u Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
- 700 1_
- $a Tung, Nadine $u Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
- 700 1_
- $a van Asperen, Christi J $u Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
- 700 1_
- $a van der Baan, Frederieke H $u Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- 700 1_
- $a van der Kolk, Lizet E $u Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
- 700 1_
- $a van der Luijt, Rob B $u Department of Medical Genetics, University Medical Center, Utrecht, the Netherlands.
- 700 1_
- $a van Hest, Liselotte P $u Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
- 700 1_
- $a Varesco, Liliana $u Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) AOU San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.
- 700 1_
- $a Varon-Mateeva, Raymonda $u Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
- 700 1_
- $a Viel, Alessandra $u Division of Functional Onco-genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
- 700 1_
- $a Vierstraete, Jeroen $u Centre for Medical Genetics, Ghent University, Ghent, Belgium.
- 700 1_
- $a Villa, Roberta $u Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy.
- 700 1_
- $a von Wachenfeldt, Anna $u Department of Oncology, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Wagner, Philipp $u Department of Women's Health, Tubingen University Hospital, Tubingen, Germany.
- 700 1_
- $a Wang-Gohrke, Shan $u Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
- 700 1_
- $a Wappenschmidt, Barbara $u Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
- 700 1_
- $a Weitzel, Jeffrey N $u Clinical Cancer Genetics, City of Hope, Duarte, California.
- 700 1_
- $a Wieme, Greet $u Centre for Medical Genetics, Ghent University, Ghent, Belgium.
- 700 1_
- $a Yadav, Siddhartha $u Department of Oncology, Mayo Clinic, Rochester, Minnesota.
- 700 1_
- $a Yannoukakos, Drakoulis $u Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research "Demokritos", Athens, Greece.
- 700 1_
- $a Yoon, Sook-Yee $u Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Selangor, Malaysia.
- 700 1_
- $a Zanzottera, Cristina $u Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy.
- 700 1_
- $a Zorn, Kristin K $u Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
- 700 1_
- $a D'Amico, Anthony V $u Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.
- 700 1_
- $a Freedman, Matthew L $u Dana-Farber Cancer Institute. Boston, Massachusetts.
- 700 1_
- $a Pomerantz, Mark M $u Dana-Farber Cancer Institute. Boston, Massachusetts.
- 700 1_
- $a Chenevix-Trench, Georgia $u Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
- 700 1_
- $a Antoniou, Antonis C $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
- 700 1_
- $a Neuhausen, Susan L $u Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California.
- 700 1_
- $a Ottini, Laura $u Department of Molecular Medicine, University La Sapienza, Rome, Italy.
- 700 1_
- $a Nielsen, Henriette Roed $u Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
- 700 1_
- $a Rebbeck, Timothy R $u Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Timothy_Rebbeck@dfci.harvard.edu. Dana-Farber Cancer Institute. Boston, Massachusetts.
- 773 0_
- $w MED00009437 $t Cancer research $x 1538-7445 $g Roč. 80, č. 3 (2020), s. 624-638
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31723001 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222155114 $b ABA008
- 999 __
- $a ok $b bmc $g 1599358 $s 1115899
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 80 $c 3 $d 624-638 $e 20191113 $i 1538-7445 $m Cancer research $n Cancer Res $x MED00009437
- GRA __
- $a 203477/Z/16/Z $p Wellcome Trust $2 United Kingdom
- GRA __
- $a CRN-87521 $p CIHR $2 Canada
- GRA __
- $a C1287/A 10710 $p Cancer Research UK $2 United Kingdom
- GRA __
- $a P50 CA116201 $p NCI NIH HHS $2 United States
- GRA __
- $a R01 CA149429 $p NCI NIH HHS $2 United States
- GRA __
- $a U19 CA148065 $p NCI NIH HHS $2 United States
- GRA __
- $a C1281/A12014 $p Cancer Research UK $2 United Kingdom
- GRA __
- $a U10 CA180822 $p NCI NIH HHS $2 United States
- GRA __
- $a U10 CA180868 $p NCI NIH HHS $2 United States
- GRA __
- $a R03 CA130065 $p NCI NIH HHS $2 United States
- GRA __
- $a R01 CA176785 $p NCI NIH HHS $2 United States
- GRA __
- $a CRN-87521 $p CIHR $2 Canada
- GRA __
- $a RC4 CA153828 $p NCI NIH HHS $2 United States
- GRA __
- $a P20 CA233255 $p NCI NIH HHS $2 United States
- GRA __
- $a R01 CA142996 $p NCI NIH HHS $2 United States
- GRA __
- $a R01 CA140323 $p NCI NIH HHS $2 United States
- GRA __
- $a P50 CA125183 $p NCI NIH HHS $2 United States
- GRA __
- $a UM1 CA164920 $p NCI NIH HHS $2 United States
- GRA __
- $a P30 CA168524 $p NCI NIH HHS $2 United States
- GRA __
- $a U01 CA161032 $p NCI NIH HHS $2 United States
- GRA __
- $a C12292/A11174 $p Cancer Research UK $2 United Kingdom
- GRA __
- $a U10 CA027469 $p NCI NIH HHS $2 United States
- GRA __
- $a C5047/A10692 $p Cancer Research UK $2 United Kingdom
- GRA __
- $a UL1 TR000124 $p NCATS NIH HHS $2 United States
- GRA __
- $a U01 CA116167 $p NCI NIH HHS $2 United States
- GRA __
- $a C5047/A8384 $p Cancer Research UK $2 United Kingdom
- GRA __
- $a P30 CA008748 $p NCI NIH HHS $2 United States
- GRA __
- $a R01 CA214545 $p NCI NIH HHS $2 United States
- GRA __
- $a C5047/A8385FCCC $p Cancer Research UK $2 United Kingdom
- GRA __
- $a R01 CA128978 $p NCI NIH HHS $2 United States
- GRA __
- $a U19 CA148537 $p NCI NIH HHS $2 United States
- GRA __
- $a P30 CA051008 $p NCI NIH HHS $2 United States
- GRA __
- $a R01 CA116167 $p NCI NIH HHS $2 United States
- GRA __
- $a C12292/A20861 $p Cancer Research UK $2 United Kingdom
- GRA __
- $a U10 CA037517 $p NCI NIH HHS $2 United States
- GRA __
- $a P20 GM130423 $p NIGMS NIH HHS $2 United States
- GRA __
- $a R25 CA112486 $p NCI NIH HHS $2 United States
- GRA __
- $a C5047/A15007 $p Cancer Research UK $2 United Kingdom
- GRA __
- $a N02CP65504 $p NCI NIH HHS $2 United States
- GRA __
- $a P50 CA105641 $p NCI NIH HHS $2 United States
- GRA __
- $a T32 CA009001 $p NCI NIH HHS $2 United States
- GRA __
- $a U19 CA148112 $p NCI NIH HHS $2 United States
- GRA __
- $a C8197/A16565 $p Cancer Research UK $2 United Kingdom
- GRA __
- $a 10118 $p Cancer Research UK $2 United Kingdom
- GRA __
- $a R01 CA192393 $p NCI NIH HHS $2 United States
- GRA __
- $a C12292/A11174 $p Cancer Research UK $2 United Kingdom
- GRA __
- $a N02CP11019 $p NCI NIH HHS $2 United States
- LZP __
- $a Pubmed-20201125